Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta-analysis and systemic review - Chang, Y H; Chang, D M; Lin, K C; Shin, S J; Lee, Y J (Diabetes Metab Res Rev, 2011)